"The absence of a statistically significant benefit of adjuvant chemotherapy in the ASTER 70s trial underlines the persistent ...

Given GLP-1 receptor agonists' established effects on weight, Poizeau and colleagues investigated whether the blockbuster ...

Novartis announces positive results from VAYHIT2 phase III trial of ianalumab plus eltrombopag in patients with primary immune thrombocytopenia: Basel Wednesday, August 13, 2025, ...

Yantai-based RemeGen said it will now move ahead with filing telitacicept with China's National Medical Products ...

Drugs to treat attention deficit hyperactivity disorder were linked to a reduced risk of suicidal behavior, substance misuse and criminality in the first research of its kind.

The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and ...

The China-based phase 3 trial of telitacicept in primary Sjögren's syndrome (pSS) met its primary endpoint, which focused on ...

The company is shifting some production from China and Mexico in a move that could soften the impact of tariffs.

A New Jersey pharmaceutical executive has been charged in connection with a high-speed, wrong-way crash that killed a former Olympic swimmer.

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

The European Union could not say when a joint statement on tariffs with the United States would be ready, nor when the White House would issue an executive or ...

In August 2025, H. Lee Moffitt Cancer Center and Research Institute conducted a study is a multi-institution, open-label, ...